{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T21:50:58Z","timestamp":1722635458137},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00108-019-0556-0","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T02:38:46Z","timestamp":1548383926000},"page":"309-314","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabis und Cannabinoide \u2013 erleichterter Zugang, Hype und Entt\u00e4uschung"],"prefix":"10.1007","volume":"60","author":[{"given":"T.","family":"Rasche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"556_CR1","volume-title":"Medizinisches Cannabis: Die wichtigsten \u00c4nderungen","author":"\u00c4rzteblatt D\u00c4G Redaktion Deutsches","year":"2017","unstructured":"\u00c4rzteblatt D\u00c4G Redaktion Deutsches (2017) Medizinisches Cannabis: Die wichtigsten \u00c4nderungen. \n                    https:\/\/www.aerzteblatt.de\/archiv\/186476\/Medizinisches-Cannabis-Die-wichtigsten-Aenderungen\n                    \n                  . Zugegriffen: 31. Dez. 2018"},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:807\u2013819. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70143-5","journal-title":"Lancet Neurol"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7","journal-title":"Lancet"},{"key":"556_CR4","first-page":"605","volume":"34","author":"WA Devane","year":"1988","unstructured":"Devane WA, Dysarz FA, Johnson MR et\u00a0al (1988) Determination and characterization of a\u00a0cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"556_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14608","author":"J Elliott","year":"2018","unstructured":"Elliott J, DeJean D, Clifford T et al (2018) Cannabis-based products for pediatric epilepsy: a systematic review. Epilepsia. \n                    https:\/\/doi.org\/10.1111\/epi.14608","journal-title":"Epilepsia"},{"key":"556_CR6","doi-asserted-by":"publisher","first-page":"CNC49","DOI":"10.2217\/cnc-2017-0010","volume":"2","author":"MB Elliott","year":"2017","unstructured":"Elliott MB, Ward SJ, Abood ME et\u00a0al (2017) Understanding the endocannabinoid system as a\u00a0modulator of the trigeminal pain response to concussion. Concussion 2:CNC49. \n                    https:\/\/doi.org\/10.2217\/cnc-2017-0010","journal-title":"Concussion"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a\u00a0systematic review and meta-analysis. Lancet Neurol 14:162\u2013173. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J\u00a0Am Chem Soc 86:1646\u20131647. \n                    https:\/\/doi.org\/10.1021\/ja01062a046","journal-title":"J Am Chem Soc"},{"key":"556_CR9","volume-title":"Cannabis legalization and regulation","author":"Government of Canada D of J","year":"2018","unstructured":"Government of Canada D of J (2018) Cannabis legalization and regulation. \n                    https:\/\/www.justice.gc.ca\/eng\/cj-jp\/cannabis\/\n                    \n                  . Zugegriffen: 1. Jan. 2019"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ejp.1297","volume":"22","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user W, Finn DP, Kalso E et al (2018) European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain 22:1547\u20131564. \n                    https:\/\/doi.org\/10.1002\/ejp.1297","journal-title":"Eur J Pain"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3238\/arztebl.2017.0627","volume":"114","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Fitzcharles M\u2011A, Radbruch L, Petzke F (2017) Cannabinoids in pain management and palliative medicine. Dtsch Arztebl Int 114:627\u2013634. \n                    https:\/\/doi.org\/10.3238\/arztebl.2017.0627","journal-title":"Dtsch Arztebl Int"},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","volume":"80","author":"AC Howlett","year":"2017","unstructured":"Howlett AC, Abood ME (2017) CB1 and CB2 receptor pharmacology. Adv Pharmacol 80:169\u2013206. \n                    https:\/\/doi.org\/10.1016\/bs.apha.2017.03.007","journal-title":"Adv Pharmacol"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","volume":"12","author":"C Ibeas Bih","year":"2015","unstructured":"Ibeas Bih C, Chen T, Nunn AVW et\u00a0al (2015) Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics 12:699\u2013730. \n                    https:\/\/doi.org\/10.1007\/s13311-015-0377-3","journal-title":"Neurotherapeutics"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanp\u00e4\u00e4 M et\u00a0al (2011) A new definition of neuropathic pain. Pain 152:2204\u20132205. \n                    https:\/\/doi.org\/10.1016\/j.pain.2011.06.017","journal-title":"Pain"},{"key":"556_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012853.pub2","author":"TS Kafil","year":"2018","unstructured":"Kafil TS, Nguyen TM, MacDonald JK, Chande N (2018) Cannabis for the treatment of Crohn\u2019s disease. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD012853.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"556_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012954.pub2","author":"TS Kafil","year":"2018","unstructured":"Kafil TS, Nguyen TM, MacDonald JK, Chande N (2018) Cannabis for the treatment of ulcerative colitis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD012954.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000360528","volume":"72","author":"CP Kamm","year":"2014","unstructured":"Kamm CP, Uitdehaag BM, Polman CH (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72:132\u2013141. \n                    https:\/\/doi.org\/10.1159\/000360528","journal-title":"Eur Neurol"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cpt.568","volume":"101","author":"D Katz","year":"2017","unstructured":"Katz D, Katz I, Porat-Katz BS, Shoenfeld Y (2017) Medical cannabis: Another piece in the mosaic of autoimmunity? Clin Pharmacol Ther 101:230\u2013238. \n                    https:\/\/doi.org\/10.1002\/cpt.568","journal-title":"Clin Pharmacol Ther"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","volume":"78","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi S, Brigo F, Trinka E et al (2018) Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs 78:1791\u20131804. \n                    https:\/\/doi.org\/10.1007\/s40265-018-0992-5","journal-title":"Drugs"},{"issue":"Suppl 1","key":"556_CR20","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/j.pain.0000000000000428","volume":"157","author":"R Maldonado","year":"2016","unstructured":"Maldonado R, Ba\u00f1os JE, Caba\u00f1ero D (2016) The endocannabinoid system and neuropathic pain. Pain 157(Suppl 1):S23\u2013S32. \n                    https:\/\/doi.org\/10.1097\/j.pain.0000000000000428","journal-title":"Pain"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ et\u00a0al (1990) Structure of a\u00a0cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564. \n                    https:\/\/doi.org\/10.1038\/346561a0","journal-title":"Nature"},{"key":"556_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012182.pub2","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Phillips T, Radbruch L et al (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD012182.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jcsm.12273","volume":"9","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Weier M, Carter C et al (2018) Systematic review and meta-analysis of cannabinoids in palliative medicine. J\u00a0Cachexia Sarcopenia Muscle 9:220\u2013234. \n                    https:\/\/doi.org\/10.1002\/jcsm.12273","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"556_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","volume":"18","author":"S Nielsen","year":"2018","unstructured":"Nielsen S, Germanos R, Weier M et\u00a0al (2018) The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a\u00a0systematic review of reviews. Curr Neurol Neurosci Rep 18:8. \n                    https:\/\/doi.org\/10.1007\/s11910-018-0814-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"556_CR25","first-page":"225","volume":"10","author":"WB O\u2019Shaughnessy","year":"1840","unstructured":"O\u2019Shaughnessy WB (1840) On the preparations of the Indian hemp, or Gunjah (cannabis Indica), their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Br Foreign Med Rev 10:225\u2013228","journal-title":"Br Foreign Med Rev."},{"key":"556_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/525S10a","volume":"525","author":"S Pain","year":"2015","unstructured":"Pain S (2015) A potted history. Nature 525:10\u201311. \n                    https:\/\/doi.org\/10.1038\/525S10a","journal-title":"Nature"},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.007","volume":"31","author":"JP Solano","year":"2006","unstructured":"Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J\u00a0Pain Symptom Manage 31:58\u201369. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.06.007","journal-title":"J. Pain Symptom Manage."},{"key":"556_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","volume":"13","author":"CJ Sorensen","year":"2017","unstructured":"Sorensen CJ, DeSanto K, Borgelt L et\u00a0al (2017) Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment\u2014a systematic review. J\u00a0Med Toxicol 13:71\u201387. \n                    https:\/\/doi.org\/10.1007\/s13181-016-0595-z","journal-title":"J Med Toxicol"},{"key":"556_CR29","unstructured":"State Medical Marijuana Laws. \n                    http:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx\n                    \n                  . Zugegriffen: 01. Januar 2019"},{"key":"556_CR30","volume-title":"WHO definition of palliative care","author":"WHO","year":"2018","unstructured":"WHO WHO definition of palliative care. \n                    https:\/\/www.who.int\/cancer\/palliative\/definition\/en\/\n                    \n                  . Zugegriffen: 31. Dez. 2018"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0556-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0556-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0556-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:05:03Z","timestamp":1579824303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0556-0"}},"subtitle":["Was ist gesichert in der Therapie?"],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0556-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"24 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Rasche, D.\u00a0Emmert, C.\u00a0Stieber, R.\u00a0Conrad und M.\u00a0M\u00fccke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}